The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLloyds Regulatory News (LLOY)

Share Price Information for Lloyds (LLOY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 52.64
Bid: 52.64
Ask: 52.66
Change: 0.34 (0.65%)
Spread: 0.02 (0.038%)
Open: 52.68
High: 52.82
Low: 52.32
Prev. Close: 52.30
LLOY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AT1 Repurchase Offer Results

31 Mar 2022 15:44

RNS Number : 8288G
Lloyds Banking Group PLC
31 March 2022
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES OF AMERICA, ITS TERRITORIES AND POSSESSIONS (INCLUDING PUERTO RICO, THE U.S. VIRGIN ISLANDS, GUAM, AMERICAN SAMOA, WAKE ISLAND AND THE NORTHERN MARIANA ISLANDS, ANY STATE OF THE UNITED STATES OF AMERICA OR THE DISTRICT OF COLUMBIA) (THE "UNITED STATES") OR TO ANY U.S. PERSON OR TO ANY OTHER PERSON WHERE OR TO WHOM IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS DOCUMENT.

 

 

LLOYDS BANKING GROUP PLC ANNOUNCES THE RESULTS OF ITS PURCHASE PROGRAMME FOR ONE SERIES OF ITS STERLING DENOMINATED ADDITIONAL TIER 1 SECURITIES

Following its announcement on 23 March 2022, Lloyds Banking Group plc ("LBG") today announces that it has accepted for purchase £421,363,000 in principal amount of the following securities (the "Securities") pursuant to a purchase programme (the "Purchase Programme") managed by Lloyds Bank Corporate Markets plc and UBS AG London Branch (together, the "Managers"):

Description of the Securities

ISIN

Amount accepted for purchase

Amount outstanding following settlement of all purchases

£1,494,392,000 7.625 per cent. Fixed Rate Reset Additional Tier 1 Perpetual Subordinated Contingent Convertible Securities Callable 2023

XS1043552188

£421,363,000

£1,073,029,000

The Purchase Period for the Purchase Programme is now closed. LBG reserves the right to continue to purchase Securities, off-market or in the market, from time to time. Securities purchased pursuant to the Purchase Programme will be cancelled by LBG.

For enquiries please contact:

Lloyds Bank Corporate Markets plc

10 Gresham StreetLondon EC2V 7AEUnited Kingdom

Tel: +44 20 7158 1726 / 1719

Attention: Liability Management Group

email: wbm-liabilitymanagement@lloydsbanking.com

UBS AG London Branch

5 BroadgateLondon EC2M 2QSUnited Kingdom

Telephone: +44 20 7568 1121

Attention: Liability Management Group

Email: ol-liabilitymanagement-eu@ubs.com

 

 

For further information please contact:

Group Corporate Treasury:

Liz PadleyHead of Capital, Holding Company, and Recovery and ResolutionTelephone: +44 (0)20 7158 1737Email: Claire-Elizabeth.Padley@LloydsBanking.com

Pascale DoreyDebt Investor RelationsTelephone: +44 (0)20 7158 1060Email: Pascale.Dorey@LloydsBanking.com

Investor Relations:

Douglas RadcliffeGroup Investor Relations DirectorTelephone: +44 (0)20 7356 1571Email: Douglas.Radcliffe@LloydsBanking.com 

Corporate Affairs:

Matthew SmithHead of Media RelationsTel: +44 (0)20 7356 3522Email: matt.smith@lloydsbanking.com

This announcement contains inside information in relation to the Securities and is disclosed in accordance with the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("UK MAR"). For the purposes of UK MAR and Article 2 of the binding technical standards published by the Financial Conduct Authority in relation to UK MAR as regards Commission Implementing Regulation (EU) 2016/1055, this announcement is made by Douglas Radcliffe, Group Investor Relations Director.

DISCLAIMER

This announcement must be read in conjunction with the announcement relating to the Purchase Programme published by LBG on 23 March 2022. Terms defined in such announcement have the same meanings when used in this announcement.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCWPUUCWUPPGCG
Date   Source Headline
29th Apr 20248:31 amRNSNotice of Redemption
26th Apr 20245:28 pmRNSTransaction in Own Shares
25th Apr 20245:50 pmRNSTransaction in Own Shares
25th Apr 20241:14 pmRNSPublication of Suppl.Prospcts
24th Apr 20246:21 pmRNSTransaction in Own Shares
24th Apr 20242:37 pmRNSPublication of Suppl.Prospcts
24th Apr 202412:29 pmRNSPublication of Suppl.Prospcts
24th Apr 202411:03 amRNS2024 Q1 Interim Management Statement
24th Apr 20247:00 amRNS2024 Q1 Interim Management Statement
23rd Apr 20246:05 pmRNSTransaction in Own Shares
22nd Apr 20245:55 pmRNSTransaction in Own Shares
19th Apr 20245:41 pmRNSTransaction in Own Shares
18th Apr 20246:01 pmRNSTransaction in Own Shares
17th Apr 20246:10 pmRNSTransaction in Own Shares
16th Apr 20246:11 pmRNSTransaction in Own Shares
15th Apr 20245:59 pmRNSTransaction in Own Shares
12th Apr 20245:57 pmRNSTransaction in Own Shares
11th Apr 20245:37 pmRNSTransaction in Own Shares
11th Apr 20242:00 pmRNSDirector/PDMR Shareholding
10th Apr 20246:02 pmRNSTransaction in Own Shares
9th Apr 20246:07 pmRNSTransaction in Own Shares
8th Apr 20246:02 pmRNSTransaction in Own Shares
4th Apr 20246:05 pmRNSTransaction in Own Shares
4th Apr 202410:10 amRNSPublication of Final Terms
3rd Apr 20246:01 pmRNSTransaction in Own Shares
2nd Apr 20245:56 pmRNSTransaction in Own Shares
28th Mar 20245:46 pmRNSTransaction in Own Shares
28th Mar 20245:39 pmRNSTotal Voting Rights
28th Mar 20245:24 pmRNSPublication of a Prospectus
28th Mar 20249:30 amRNSBlock Listing of Shares
27th Mar 20246:10 pmRNSTransaction in Own Shares
26th Mar 20245:53 pmRNSTransaction in Own Shares
26th Mar 20242:00 pmRNSDirector/PDMR Shareholding
25th Mar 20245:34 pmRNSTransaction in Own Shares
22nd Mar 20246:14 pmRNSPublication of a Prospectus
21st Mar 20246:13 pmRNSTransaction in Own Shares
21st Mar 20244:28 pmRNSNotice of AGM
20th Mar 20246:16 pmRNSTransaction in Own Shares
19th Mar 20246:18 pmRNSTransaction in Own Shares
18th Mar 20246:19 pmRNSTransaction in Own Shares
15th Mar 20246:05 pmRNSTransaction in Own Shares
15th Mar 20242:00 pmRNSDirector/PDMR Shareholding
14th Mar 20245:58 pmRNSTransaction in Own Shares
13th Mar 20246:23 pmRNSTransaction in Own Shares
13th Mar 20243:00 pmRNSDirector/PDMR Shareholding
12th Mar 20246:16 pmRNSTransaction in Own Shares
11th Mar 20246:16 pmRNSTransaction in Own Shares
8th Mar 20245:33 pmRNSTransaction in Own Shares
8th Mar 20241:30 pmRNSDirector/PDMR Shareholding
7th Mar 20246:06 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.